Björkman A, Rombo L, Hetland G, Willcox M, Hanson A P
Ann Trop Med Parasitol. 1985 Dec;79(6):603-6. doi: 10.1080/00034983.1985.11811967.
The in vivo and in vitro susceptibility of Plasmodium falciparum to chloroquine was investigated in northern Liberia after 20 years of continuous chemosuppression and therapy with 4-aminoquinolines. In all patients studied (n = 53) parasitaemias were cleared within four days. There were no recrudescences in 16 patients followed-up for 28 days. All isolates of P. falciparum tested in vitro (n = 26) showed sensitive patterns. Schizont maturation was inhibited by a chloroquine concentration of between 0.25 and 0.75 mumol-1. In this area of Liberia no resistance to chloroquine was found in spite of extensive use of 4-aminoquinolines. This may support the view that importation of at least partially resistant strains, rather than local mutation of P. falciparum, precedes selection of resistant strains. Hence, we conclude that regular intake of chloroquine by groups at risk is justified if it is combined with regular monitoring of drug susceptibility.
在利比里亚北部,经过20年持续使用4-氨基喹啉进行化学抑制和治疗后,对恶性疟原虫对氯喹的体内和体外敏感性进行了研究。在所有研究的患者(n = 53)中,疟原虫血症在四天内清除。16名随访28天的患者没有复发。所有体外测试的恶性疟原虫分离株(n = 26)均显示敏感模式。氯喹浓度在0.25至0.75 μmol-1之间时,裂殖体成熟受到抑制。尽管广泛使用4-氨基喹啉,但在利比里亚的该地区未发现对氯喹的耐药性。这可能支持这样一种观点,即至少部分耐药菌株的输入,而非恶性疟原虫的局部突变,先于耐药菌株的选择。因此,我们得出结论,如果对有风险的群体定期服用氯喹并结合定期监测药物敏感性,是合理的。